Literature DB >> 28036118

The phenomenon of released-activity. Reply on comment on Don et al.: Dose-dependent antiviral activity of released-active form of antibodies to interferon-gamma against influenza A/California/07/09(H1N1) in murine model.

Еlena S Don1, Alexandra G Emelyanova1, Natalia N Yakovleva2, Nataliia V Petrova1, Marina V Nikiforova2, Evgeniy A Gorbunov2, Sergey А Tarasov2, Sergey G Morozov1, Оleg I Epstein1.   

Abstract

This text is aimed to provide the readers with detailed information about phenomenon of released-activity and reply on the specific risen questions.
© 2017 Wiley Periodicals, Inc.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28036118     DOI： 10.1002/jmv.24759

Source DB:  PubMed          Journal:  J Med Virol        ISSN： 0146-6615            Impact factor:   2.327


  2 in total

1.  Expression of Concern on "The Novel Oral Drug Subetta Exerts an Antidiabetic Effect in the Diabetic Goto-Kakizaki Rat: Comparison with Rosiglitazone".

Authors: 
Journal:  J Diabetes Res       Date:  2019-06-16       Impact factor: 4.011

2.  Dose-Response Effect of Antibodies to S100 Protein and Cannabinoid Receptor Type 1 in Released-Active Form in the Light-Dark Test in Mice.

Authors:  Elena V Kardash; Irina A Ertuzun; Gul'nara R Khakimova; Andrey N Kolyadin; Sergey A Tarasov; Stéphanie Wagner; Emile Andriambeloson; Vladimir T Ivashkin; Oleg I Epstein
Journal:  Dose Response       Date:  2018-06-26       Impact factor: 2.658
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.